BRITTANY MIRE: Open Payments
NPI 1093251472 · THIBODAUX, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$76 in 3 payments from 3 companies in 2025. Trend: 2023 $266 · 2024 $16 · 2025 $76
Food & beverage: $76
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 1 | $30 |
| Vanda Pharmaceuticals Inc. | 1 | $23 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $23 |
Products named: INGREZZA, FANAPT, CAPLYTA.
Industry payments across LA — which companies pay providers there.
